ERBB2 and breast carcinoma: Examples of this approach are 1) Vollebergh MA et al., proposed an array CGH classifier derived from BRCA1-mutated cancer patients and subsequently tested it on predicting response to platinum in HR+HER2-negative breast cancer patients [8].